# Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

> **NCT00003082** · PHASE1 · COMPLETED · sponsor: **University of Arizona** · enrollment: 27 (estimated)

## Conditions studied

- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Precancerous/Nonmalignant Condition
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** monoclonal antibody A27.15
- **BIOLOGICAL:** monoclonal antibody E2.3

## Key facts

- **NCT ID:** NCT00003082
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** 2001-02
- **Final completion:** 2001-02
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2010-03-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003082, "Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*